1-3 of 3
Authors: Steven Couch
Sort by
Journal Article
Efficacy and Safety of Teprotumumab in Patients With Thyroid Eye Disease of Long Duration and Low Disease Activity Open Access
Raymond S Douglas and others
The Journal of Clinical Endocrinology & Metabolism, Volume 109, Issue 1, January 2024, Pages 25–35, https://doi.org/10.1210/clinem/dgad637
Published: 31 October 2023
Journal Article
SAT455 A Randomized, Quadruple-masked, Placebo-controlled, Multicenter Trial To Evaluate The Efficacy And Safety Of Teprotumumab In Patients With Chronic (Inactive/Low CAS) Thyroid Eye Disease Open Access
Raymond S Douglas and others
Journal of the Endocrine Society, Volume 7, Issue Supplement_1, October-November 2023, bvad114.1930, https://doi.org/10.1210/jendso/bvad114.1930
Published: 05 October 2023
Journal Article
OR27-04 Efficacy And Safety Results From The Randomized, Placebo-controlled Multicenter Trial With Teprotumumab In Chronic-Low Clinical Activity Score Thyroid Eye Disease Patients Open Access
Raymond S Douglas and others
Journal of the Endocrine Society, Volume 7, Issue Supplement_1, October-November 2023, bvad114.2055, https://doi.org/10.1210/jendso/bvad114.2055
Published: 05 October 2023
Advertisement
Advertisement